Navigation Links
PDL BioPharma Provides $70 Million in Financing to Durata Therapeutics
Date:11/6/2013

d to increase the availability of any "new antibacterial or antifungal drug for human use intended to treat serious or life-threatening infections, including those caused by an antibacterial or antifungal resistant pathogen, including novel or emerging infectious pathogens…."

The total financing of up to $70 million was provided pursuant to a credit agreement that included an initial $25 million in cash funded to Durata on October 31, 2013, and provides up to $45 million in additional funds to Durata, with $15 million of funding upon U.S. regulatory approval of dalbavancin, and the remaining $30 million funded within nine months after regulatory approval of dalbavancin, at Durata's election. 

"We are pleased to provide this non-dilutive financing to Durata.  Based upon our extensive due diligence, we believe that dalbavancin will be a medically and commercially significant product," said John P. McLaughlin, president and chief executive officer of PDL. "This deal with Durata marks the fourth transaction we have closed in recent weeks and, in doing so, we believe that we are securing measurable value for PDL and our stockholders."

"We are very pleased to announce this debt financing with PDL, which we believe further validates the opportunity Durata has with dalbavancin.   This structure provides Durata with operating capital now and the flexibility for future funding, without diluting our existing shareholders, something we find very valuable," said Paul R. Edick, chief executive officer of Durata. "With the strengthened balance sheet, we are able to enhance our existing pre-commercialization and planned launch activities,"  Mr. Edick continued.

About Durata Therapeutics, Inc.

Durata Therapeutics is a pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute il
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
2. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
3. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
4. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
5. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
6. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
7. S1 Biopharma Expands Focus to Include Male Sexual Health
8. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
9. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
10. Cell Therapeutics Aequus BioPharma Validates its Proprietary GlycoPolymer Technology for the Extension of the Half-life of Therapeutic Protein Drugs
11. Galena Biopharma, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... YORK , Dec. 17, 2014 ... imaging (MRI), the MRI market is seeing new ... and breast MRI scans account for the majority ... a higher resolution of images, which are creating opportunities ... imaging (MRI) market is growing at a rate ...
(Date:12/17/2014)... MILAN , December 17, 2014 ... becoming nothing less than a hub of information concerning the ... A further addition to the recently launched ... world and has now been enriched by a new chapter ... A richly detailed and panoramic hub on ...
(Date:12/17/2014)... BUENA, N.J. , Dec. 17, 2014  IGI ... announced today the closing of its offering of $125 ... due 2019 (the "Notes").  The Notes were offered and ... 144A under the Securities Act of 1933, as amended ... at a fixed rate of 3.75% per year, payable ...
Breaking Medicine Technology:Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4
... According to new data published in Clinical ... have a significant impact on whether patients take it ... packaging from MeadWestvaco Corp. (NYSE: MWV ), ... improvement in prescription adherence behavior in patients when compared ...
... YORK, June 16, 2011 Reportlinker.com announces that ... its catalogue: US Wound Closure ... http://www.reportlinker.com/p0555195/US-Wound-Closure-Devices-–-Market-Trend-Till-2016.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment Short ... vital market data on the wound closure devices ...
Cached Medicine Technology:Shellpak® Demonstrates Statistically Significant Improvement in Patient Medication Adherence 2Shellpak® Demonstrates Statistically Significant Improvement in Patient Medication Adherence 3Shellpak® Demonstrates Statistically Significant Improvement in Patient Medication Adherence 4Shellpak® Demonstrates Statistically Significant Improvement in Patient Medication Adherence 5Reportlinker Adds US Wound Closure Devices - Market Trend Till 2016 2
(Date:12/15/2014)... a leading mobile app development company , custom ... which allows users to keep track of wines they ... right wine. At the center of WineMatch is ... wine information. All this information is assembled to help ... are close counterparts to one another are called Matches. ...
(Date:12/15/2014)... 2014 Health Dialog, a leading ... that it has received Patient Oriented Accreditation from ... its Disease Management (DM) Programs for asthma, congestive ... heart disease and diabetes. This marks the 12th ... Dialog’s Disease Management (DM) Programs, reaffirming Health Dialog’s ...
(Date:12/15/2014)... SUNDAY, Dec. 14, 2014 (HealthDay News) -- Expert pilots ... which explains why they make better decisions during landings, ... the most difficult techniques for pilots to master, and ... of fatal crashes occur during final approach and landing. ... pilots and 12 moderately experienced pilots while they were ...
(Date:12/15/2014)... (PRWEB) December 15, 2014 Kathy McAfee, ... prestigious Women World Awards in the category of Best ... gold award for her weekly career blog Networking ... advice to help professionals elevate their talent and influence ... blog, named after her book Networking Ahead for Business, ...
(Date:12/15/2014)... Portland, OR (PRWEB) December 15, 2014 ... NAIRO seeks to bring attention to restrictive state ... new position paper on this important area of ... State Laws Can Compromise the Integrity of Independent ... quality and access of independent peer review determinations ...
Breaking Medicine News(10 mins):Health News:Use WinMatch Connect App to Keep Track of Wines You Like 2Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2Health News:Study Shows Why Expert Pilots Are Experts 2Health News:Kathy McAfee, America’s Marketing Motivator, Wins Best Blog from Women World Awards 2Health News:NAIRO Calls for Higher Quality Independent Peer Review By Ending Restrictive State Laws 2
... Process Expected to Last Several Weeks; Decision Anticipated ... Secretary,of Labor Ray Marshall, the outside hearing officer ... Monday night set a,multi-week schedule for rendering his ... is slated for September 26 and 27., ...
... the Need for Adults Age 55 and Over ... Action Once Symptoms are Suspected, WASHINGTON, D.C., ... disease (AD) screening and detection, there are,striking differences ... online survey of 1,040 adults age 55 and ...
... Sick & Elderly at ... Facilities Owned By Windsor Healthcare, FREMONT, Calif., Sept. 24 ... practice strike Wednesday morning to,protest Windsor Healthcare Management,s refusal to ... sick and elderly in,Bay Area nursing homes. Windsor has responded ...
... Special Report: New innovative treatment approaches in Alzheimer,s ... attack on amyloid plaques have emerged as the ... 2008. These approaches were presented at ICAD 2008, ... new developments are discussed in the debut of ...
... Tiffany, to Link Pediatric Critical Care to ... England and the Dominican Republic, BOSTON, Mass., Sept. 24 ... announce the inaugural David Ortiz Celebrity,Golf Classic in his native ... David Ortiz Children,s Fund which,is dedicated to raising funds for ...
... 2008 Compensation Data survey results found that 67.3 percent of ... their family. , ... Kansas City, ... employers and employees continue to see high health insurance costs. ...
Cached Medicine News:Health News:Hearing Officer Secretary Ray Marshall Sets Process For United Healthcare Workers-West Trusteeship Hearing 2Health News:New Alzheimer's Disease Survey Reveals Disparities Between Beliefs and Behavior in Pursuing Diagnosis 2Health News:New Alzheimer's Disease Survey Reveals Disparities Between Beliefs and Behavior in Pursuing Diagnosis 3Health News:New Alzheimer's Disease Survey Reveals Disparities Between Beliefs and Behavior in Pursuing Diagnosis 4Health News:New Alzheimer's Disease Survey Reveals Disparities Between Beliefs and Behavior in Pursuing Diagnosis 5Health News:Caregivers Hold Unfair Labor Practice Strike to Improve Quality of Resident Care at Statewide Nursing Home Chain 2Health News:Caregivers Hold Unfair Labor Practice Strike to Improve Quality of Resident Care at Statewide Nursing Home Chain 3Health News:World Alzheimer's Day 2008 Special Report: New Alzheimer Targets Take Center Stage 2Health News:Ortiz to Host Celebrity Golf Tournament to Benefit The David Ortiz Children's Fund 2Health News:Health Insurance Premium Costs High for Employers and Employees 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: